ArticleCureus2025
A Service Evaluation of Antenatal Detection of Small-for-Gestational-Age Infants in a UK National Health Service Trust.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Infants with a birthweight below the 10th centile are classified as small-for-gestational age (SGA). SGA is closely associated with fetal growth restriction (FGR), and both represent significant risk factors for stillbirth. The UK continues to report comparatively high stillbirth rates, and antenatal detection of SGA is a recognised strategy for reducing this risk. This service evaluation assessed the antenatal detection rate of SGA infants at Mid Yorkshire Hospitals NHS Trust (MYHT). Methods This was a retrospective observational cohort service evaluation conducted between January and March 2020 using total-population sampling of all eligible cases. Using the BadgerNet maternity system, 124 SGA infants were identified, of which 110 were included after applying eligibility criteria. Data were collected on 12 potential risk factors, including maternal age, medical comorbidities, and history of SGA births. The overall detection rate for the Trust was calculated, and a multivariable (binary) logistic regression was performed using IBM SPSS Statistics for Windows, Version 26 (Released 2019; IBM Corp., Armonk, New York, United States) following descriptive analysis in Microsoft Excel. Missing data were addressed using multiple imputation, and supplementary analyses were conducted for contextual understanding. Results A total of 42.7% of SGA infants were detected in the antenatal period; 97.9% of these were identified following referral for an abnormal symphyseal fundal height (SFH) measurement. The regression model was statistically significant, χ²(12) = 47.7-50.9, p < 0.001. Maternal smoking was associated with a 3.9-fold increase in detection (95% CI, 1.01-14.9), while referral after an abnormal SFH measurement increased the likelihood of detection by 154-fold (95% CI, 14.9-1603.4). Conclusions The antenatal detection rate of SGA infants at MYHT mirrors the national average, yet most cases remain undetected across the UK. Detection was primarily driven by referral after abnormal SFH measurements, underscoring the value of routine screening. Maternal smoking also independently increased detection, reflecting its strong association with fetal growth restriction. National adoption of customised centiles in systems such as BadgerNet may improve alignment with clinical practice, support earlier recognition of at-risk pregnancies, and contribute to reducing stillbirth rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.